Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing antihypertensive treatment in clinical practice.

Jan N Basile1

  • 1Ralph H. Johnson VA Medical Center, Department of Medicine, Division of General Internal Medicine/Geriatrics, Medical University of South Carolina, 109 Bee Street, Charleston, SC 29401, USA. Jan.Basile@med.va.gov

American Journal of Hypertension
|September 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design.

JACC. Advances·2026
Same author

Hickam's Dictum in Hypertension.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Managing Hypertension in Older Adults.

Current hypertension reports·2023
Same author

How We Got Where We Are in Blood Pressure Targets.

Current hypertension reports·2021
Same author

Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs.

Hypertension (Dallas, Tex. : 1979)·2020
Same author

Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association.

Circulation·2020

Beta-blockers are crucial for managing hypertension, especially in patients with comorbidities like diabetes or heart failure. They play a vital role in optimizing blood pressure control and reducing cardiovascular disease risk.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Hypertension impacts millions globally, with cardiovascular disease as a leading cause of death.
  • Effective blood pressure control (<140/90 mm Hg) significantly reduces cardiovascular risk and improves quality of life.
  • Current guidelines emphasize the need for multiple agents to achieve blood pressure goals, particularly for high-risk patients.

Purpose of the Study:

  • To explore the cardioprotective role of beta-blockers in optimizing antihypertensive treatment.
  • To highlight the importance of beta-blockers in managing hypertension, especially in patients with specific comorbidities.

Main Methods:

  • Review of clinical trials (e.g., HOT, TOMHS) demonstrating the benefits of blood pressure control.
  • Analysis of current hypertension management guidelines regarding combination therapy.

Related Experiment Videos

  • Exploration of the role of beta-blockers as initial or add-on therapy.

    • Main Results:

    • Blood pressure reduction, even in high-risk patients like those with diabetes, lowers cardiovascular disease risk.
    • Most patients require two or more antihypertensive agents for effective blood pressure control.
    • Beta-blockers are valuable in hypertension management, particularly for patients with heart failure, diabetes, post-myocardial infarction, or high coronary disease risk.

    Conclusions:

    • Beta-blockers are essential in optimizing antihypertensive regimens.
    • Their use is particularly beneficial in hypertensive patients with specific comorbidities, offering cardioprotective effects.
    • Achieving target blood pressure goals often necessitates combination therapy, with beta-blockers playing a key role.